losartan has been researched along with Adrenal Cancer in 4 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study using a rat pheochromocytoma cell line, which expresses AT2 exclusively, we found that angiotensin II inhibits phosphotyrosine phosphatase activity in vivo as measured by the inhibition of hydrolysis of [32P]-phosphate from the 32P-labeled synthetic peptide substrate, Raytide." | 7.69 | Protein tyrosine phosphatase inhibition by angiotensin II in rat pheochromocytoma cells through type 2 receptor, AT2. ( Bardhan, S; Inagami, T; Kambayashi, Y; Shirai, H; Takahasi, K, 1994) |
| "Patients with an aldosterone-producing adenoma (APA) characteristically fail to show an increase in plasma aldosterone (PA) concentration with maneuvers that increase angiotensin II (Ang II), yet they retain a brisk response of PA to adrenocorticotrophic hormone." | 7.68 | Angiotensin II receptor subtypes on adrenal adenoma in primary hyperaldosteronism. ( Cook, MD; Cook, VI; Kimura, B; Phillips, MI; Wilcox, CS, 1993) |
| " In the present study using a rat pheochromocytoma cell line, which expresses AT2 exclusively, we found that angiotensin II inhibits phosphotyrosine phosphatase activity in vivo as measured by the inhibition of hydrolysis of [32P]-phosphate from the 32P-labeled synthetic peptide substrate, Raytide." | 3.69 | Protein tyrosine phosphatase inhibition by angiotensin II in rat pheochromocytoma cells through type 2 receptor, AT2. ( Bardhan, S; Inagami, T; Kambayashi, Y; Shirai, H; Takahasi, K, 1994) |
| "Patients with an aldosterone-producing adenoma (APA) characteristically fail to show an increase in plasma aldosterone (PA) concentration with maneuvers that increase angiotensin II (Ang II), yet they retain a brisk response of PA to adrenocorticotrophic hormone." | 3.68 | Angiotensin II receptor subtypes on adrenal adenoma in primary hyperaldosteronism. ( Cook, MD; Cook, VI; Kimura, B; Phillips, MI; Wilcox, CS, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Novosel, A | 1 |
| Heger, A | 1 |
| Lohse, P | 1 |
| Schmidt, H | 1 |
| Takahasi, K | 1 |
| Bardhan, S | 1 |
| Kambayashi, Y | 1 |
| Shirai, H | 1 |
| Inagami, T | 1 |
| Cook, MD | 1 |
| Phillips, MI | 1 |
| Cook, VI | 1 |
| Kimura, B | 1 |
| Wilcox, CS | 1 |
| Speth, RC | 1 |
| Kim, KH | 1 |
4 other studies available for losartan and Adrenal Cancer
| Article | Year |
|---|---|
Multiple pheochromocytomas and paragangliomas in a young patient carrying a SDHD gene mutation.
Topics: Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Angiotensin II Type 1 Recep | 2004 |
Protein tyrosine phosphatase inhibition by angiotensin II in rat pheochromocytoma cells through type 2 receptor, AT2.
Topics: Adrenal Gland Neoplasms; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compoun | 1994 |
Angiotensin II receptor subtypes on adrenal adenoma in primary hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Angioten | 1993 |
Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6 angiotensin II.
Topics: Adrenal Gland Neoplasms; Angiotensin II; Animals; Binding, Competitive; Cell Membrane; Guanosine 5'- | 1990 |